Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins
PD-1/PD-L1 blockade has revolutionized the field of immunooncology. Despite the relative success, the response rate to anti-PD-1 therapy requires further improvements. Our aim was to explore the enhancement of T-cell function by using novel PD-1-blocking proteins and compare with clinically approved...
Saved in:
| Main Authors: | Emelie Foord, Charlotte Klynning, Esther Schoutrop, Judith M. Förster, Jennifer Krieg, Anette Mörtberg, Mischa R. Müller, Christel Herzog, Dieter Schiegg, Denis Villemagne, Ulrike Fiedler, Dan Snell, Benjamin Kebble, Jonas Mattsson, Victor Levitsky, Michael Uhlin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2020/7375947 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DARPin-fused T cell engager for adenovirus-mediated cancer therapy
by: Patrick C. Freitag, et al.
Published: (2024-09-01) -
In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.
by: Pavel Pugach, et al.
Published: (2010-08-01) -
Preparation of Polarity-Marked Microtubules Using a Plus-End Capping DARPin
by: Gil Henkin, et al.
Published: (2024-11-01) -
PTT-Mediated Inhibition of Cancer Proliferation and Tumor Progression by DARPin-Coated Gold Nanoparticles
by: Galina M. Proshkina, et al.
Published: (2025-01-01) -
A large, general and modular DARPin–apoferritin scaffold enables the visualization of small proteins by cryo-EM
by: Xin Lu, et al.
Published: (2025-05-01)